Although anionic peptides with anticancer activity have been found, CAPs are the most abundant AMPs, acting by selectively and electrostatically interacting and disrupting cancer cell membranes (membranolytic actions) and/or by entering the cells and interacting with intracellular components (non-membranolytic actions). The gene discussed is CAPS; the disease is cancer.